Alexion Pharma (Switzerland)

Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion

Antti Väkevä, Azin Agah, Scott A. Rollins et al. · Circulation · 1998 · 392 citations · Full text

Genetic Variants in C5 and Poor Response to Eculizumab

Jun‐ichi Nishimura, Masaki Yamamoto, Shin Hayashi et al. · New England Journal of Medicine · 2014 · 392 citations · Full text

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv

Thomas C. Thomas, Scott A. Rollins, Russell P. Rother et al. · Molecular Immunology · 1996 · 359 citations

Single-chain Fv, Allergy, Autoimmune Disease +10

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.

Yijun Wang, Scott A. Rollins, Joseph A. Madri et al. · Proceedings of the National Academy of Sciences · 1995 · 356 citations · Full text

Immunology, Immunotherapy, Inflammatory Arthritis +17

Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.

William L. Fodor, B. L. Williams, Louis A. Matis et al. · Proceedings of the National Academy of Sciences · 1994 · 348 citations · Full text

Histocompatibility, Immunology, Biomedical Engineering +16